May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Genotype–Phenotype Study in Autosomal Dominant Retinitis Pigmentosa With PRPF31 Mutations (RP11): Incomplete Penetrance or Variable Expressivity?
Author Affiliations & Notes
  • V. Vaclavik
    Moorfields Eye Hospital, London, United Kingdom
    Institute of Ophthalmology, London, United Kingdom
  • N.H. Waseem
    Institute of Ophthalmology, London, United Kingdom
  • R. Kirby
    Moorfields Eye Hospital, London, United Kingdom
  • S.A. Jenkins
    Moorfields Eye Hospital, London, United Kingdom
  • G.E. Holder
    Moorfields Eye Hospital, London, United Kingdom
  • A.G. Robson
    Moorfields Eye Hospital, London, United Kingdom
  • A.C. Bird
    Institute of Ophthalmology, London, United Kingdom
  • A.R. Webster
    Moorfields Eye Hospital, London, United Kingdom
    Institute of Ophthalmology, London, United Kingdom
  • S.S. Bhattacharya
    Institute of Ophthalmology, London, United Kingdom
  • Footnotes
    Commercial Relationships  V. Vaclavik, None; N.H. Waseem, None; R. Kirby, None; S.A. Jenkins, None; G.E. Holder, None; A.G. Robson, None; A.C. Bird, None; A.R. Webster, None; S.S. Bhattacharya, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1701. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      V. Vaclavik, N.H. Waseem, R. Kirby, S.A. Jenkins, G.E. Holder, A.G. Robson, A.C. Bird, A.R. Webster, S.S. Bhattacharya; Genotype–Phenotype Study in Autosomal Dominant Retinitis Pigmentosa With PRPF31 Mutations (RP11): Incomplete Penetrance or Variable Expressivity? . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1701.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Autosomal dominant retinitis pigmentosa due to mutation in PRPF31 (RP11) is unusual in that non–penetrance can occur in mutation carriers. The aim was to determine the disease expression in patients from 8 families with defined mutations. The asymptomatic obligate carriers were assessed, in order to determine the prevalence of pre–symptomatic expression of the mutation.

Methods: : 35 patients from 8 families carrying 6 distinct mutations in the PRPF31 gene were ascertained and included 18 affected (20–85 yrs) and 4 asymptomatic obligate carriers (39–77yrs). All underwent ophthalmic examination, color vision testing, digital fundus photography, autofluorescence (AF) imaging and ocular coherence tomography (OCT). Some patients, including obligate carriers, had ISCEV–standard full–field electroretinography (ERG) and Goldman perimetry. Disease variability was assessed between subjects within the same family as well as between different families.

Results: : Age of onset of nightblindness and severity of progression of the disease was variable between members of the same family. Important phenotype variability was noticed among families with different mutations. There was no correlation between phenotype and type of mutation. All asymptomatic obligate carriers had a normal visual acuity and normal fundus appearance. Full–field ERGs revealed generalised rod and cone dysfunction. The AF imaging of one obligate carrier showed a large high density ring bilaterally.

Conclusions: : Mutations in PRPF31 cause a variable phenotype and there is no correlation with the mutation. Those non–penetrant for symptoms and retinal signs may manifest definite abnormalities on electrophysiology and autofluorescence imaging.

Keywords: genetics • gene/expression • electrophysiology: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×